BB

Benjamin E. Blass

TU Temple University: 20 patents #3 of 364Top 1%
BC Biohaven Pharmaceutical Holding Company: 5 patents #3 of 10Top 30%
RJ Rutgers, The State University Of New Jersey: 4 patents #174 of 1,498Top 15%
The Procter & Gamble: 4 patents #2,952 of 10,133Top 30%
Pfizer: 2 patents #2,078 of 5,153Top 45%
SB Shifa Biomedical: 1 patents #5 of 9Top 60%
📍 Eagleville, PA: #2 of 58 inventorsTop 4%
🗺 Pennsylvania: #1,639 of 74,527 inventorsTop 3%
Overall (All Time): #110,299 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 26–32 of 32 patents

Patent #TitleCo-InventorsDate
9464062 Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators Daniel J. Canney, Richie R. Bhandare, Magid A. Abou-Gharbia 2016-10-11
7803827 Kv1.5 potassium channel inhibitors John Michael Janusz, Stephen Joseph Hodson, Gregory Kent Bosch, Ronald E. White, Christopher M. Jackson +1 more 2010-09-28
7504517 Kv1.5 potassium channel inhibitors John Michael Janusz, Stephen Joseph Hodson, Gregory Kent Bosch, Ronald E. White, Christopher M. Jackson +1 more 2009-03-17
6787555 Triazole compounds useful in treating diseases associated with unwanted cytokine activity Joshua Spector Tullis, John Charles Van Rens, Michael P. Clark, Michael G. Natchus, Biswanath De 2004-09-07
6727364 Triazole compounds useful in treating diseases associated with unwanted cytokine activity Joshua Spector Tullis, John Charles Van Rens, Michael P. Clark, Michael G. Natchus, Biswanath De 2004-04-27
6635769 Process for making functionalized oxazolidinone compounds 2003-10-21
6596739 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses Song Liu, David Edward Portlock 2003-07-22